Literature DB >> 9446096

[Primary chronic osteomyelitis].

G Jundt1, L Jani.   

Abstract

The term primary chronic osteomyelitis covers a heterogeneous spectrum of clinical features that should be separated for therapeutic reasons. Unifocal manifestations should be distinguished from multifocal ones. While bacteria are often found in the first group, bacteriological investigations are usually negative in the second group. Additionally, multifocal forms often recur (chronic multifocal recurrent osteomyelitis), possess a long clinical course and may be combined with dermatological disorders (SAPHO syndrome). A biopsy is often necessary for tumor exclusion and obtaining material for bacteriology. Histology cannot differentiate between the respective forms of chronic osteomyelitis.

Entities:  

Mesh:

Year:  1997        PMID: 9446096     DOI: 10.1007/PL00003338

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  4 in total

1.  Medium-term results after total clavicle resection in cases of osteitis: a consecutive case series of five patients.

Authors:  Ralf Oheim; Arndt Peter Schulz; Rita Schoop; Cornelius H Grimme; Justus Gille; Ulf-Joachim Gerlach
Journal:  Int Orthop       Date:  2011-09-01       Impact factor: 3.075

2.  [Medium-term results of surgical treatment for osteitis of the clavicle].

Authors:  R Oheim; J Gille; C H Grimme; D Hadler; S Wallstabe; U J Gerlach
Journal:  Unfallchirurg       Date:  2011-07       Impact factor: 1.000

3.  Surgical therapy of extensive knee joint empyema: mid-term results after two-stage versus one-stage procedures.

Authors:  Ralf Oheim; Justus Gille; Rita Schoop; Sylvia Badih; Cornelius H Grimme; Arndt-Peter Schulz; Christian Jürgens; Ulf-Joachim Gerlach
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-12       Impact factor: 4.342

4.  [Osteomyelitis in children].

Authors:  H-G Dietz; A Bachmeyr; I Joppich
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.